-
Multiple Sclerosis Therapeutics Market Expected to Expand at a Steady 2024-2031 | Bayer AG, Pfizer, Inc., Biogen Idec
10 Apr 2024 07:23 GMT
… .A.
◘ Bayer AG
◘ Pfizer Inc.
◘ Biogen Idec
◘ Merck & Co. Inc.
◘ AbbVie … market.
➞ Assess and project market shares for significant segments within the …
-
US Shares
18 Oct 2024 21:18 GMT
Business World, Ireland's leading source for Financial and Business news brings you the latest market share prices from the US as they occur.
Name
Latest
Change
Previous
Day Hi
Day Lo
Details
21ST CENTRY FOX A CM
24.12
-0.1
24.22
24.59
24.09
More
…
-
Cipla receives final approval for generic version of Biogen IDEC Inc.'s Tecfidera®
25 Sep 2020 04:52 GMT
… generic therapeutic equivalent version of Biogen IDEC Inc.'s Tecfidera®. It … will providing Co-Pay Assistance.
Shares of CIPLA LTD. was last … .9. The total number of shares traded during the day was …
-
India- Auto Injectors Market 2019: Industry Analysis and Detailed Profiles of Top Industry Players Antares Pharma Inc., Biogen, IDEC Inc., BD, Dickinson and Company
21 Mar 2019 22:10 GMT
… are Antares Pharma, Inc., Biogen Idec, Inc., Becton, Dickinson … Dickinson and Company, Unilife Corporation Biogen Idec, Inc., Antares Pharma, Inc … The report includes market shares of the global auto … The latest developments, market shares, and strategies that …
-
Keros Therapeutics Highlights Commitment to Maximizing Stockholder Value
19 May 2025 12:00 GMT
… holding less than 24,000 shares of the Company, but since … with Idec Pharma to form Biogen Idec
Insights into evolving drug markets … IMPORTANT, NO MATTER HOW MANY SHARES YOU OWN.
YOU MAY VOTE … any assistance with voting your shares, please contact:
7 Penn …
-
Inozyme Pharma Reports First Quarter 2025 Financial Results And Provides Business Highlights
14 May 2025 12:19 GMT
… Therapeutics, led neurology programs at Biogen Idec, and supported medical affairs and … (0.38 ) Weighted-average common shares outstanding-basic and diluted 64 …
-
Inozyme Pharma Reports First Quarter 2025 Financial Results and Provides Business Highlights
14 May 2025 11:30 GMT
… Therapeutics, led neurology programs at Biogen Idec, and supported medical affairs and …
(0.38
)
Weighted-average common shares outstanding—basic and diluted
64 …
-
Covid-19 Impact on Vitamin D Analogs Market Size, Global Trends Analysis, Top Manufacturers, Shares, Growth Opportunities, Statistics & Forecast to 2026
29 May 2021 09:49 GMT
The MarketWatch News Department was not involved in the creation of this content.
May 29, 2021 (Market Insight Reports) --
Changsha, China, HongChun Research: Overview for "Vitamin D Analogs Market" Helps in providing scope and definitions, Key …
-
Cipla shares gain 5% after USFDA okays capsules; m-cap rises by Rs 3,021 cr
25 Sep 2020 19:32 GMT
Shares of drug firm Cipla on … generic therapeutic equivalent version of Biogen IDEC Inc's Tecfidera.
Cipla …
About
© 1995-2025